CATALOGO DEI PRODOTTI DELLA RICERCA

CALABRESE, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.014
AS - Asia 3.343
EU - Europa 3.328
SA - Sud America 520
AF - Africa 87
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.941
SG - Singapore 1.291
CN - Cina 1.058
IT - Italia 614
GB - Regno Unito 589
BR - Brasile 468
HK - Hong Kong 415
DE - Germania 377
RU - Federazione Russa 338
SE - Svezia 316
FR - Francia 293
FI - Finlandia 267
IE - Irlanda 255
VN - Vietnam 123
KR - Corea 121
TR - Turchia 114
UA - Ucraina 54
AT - Austria 52
ID - Indonesia 52
NL - Olanda 42
CA - Canada 35
TG - Togo 35
IN - India 28
ES - Italia 22
BE - Belgio 21
MX - Messico 21
PL - Polonia 20
JP - Giappone 19
AR - Argentina 18
BD - Bangladesh 18
ZA - Sudafrica 14
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
MK - Macedonia 11
AU - Australia 10
EC - Ecuador 10
MA - Marocco 10
AZ - Azerbaigian 9
IQ - Iraq 9
CZ - Repubblica Ceca 7
HR - Croazia 7
IL - Israele 6
JO - Giordania 6
LT - Lituania 6
PT - Portogallo 6
PY - Paraguay 6
CH - Svizzera 5
DZ - Algeria 5
EG - Egitto 5
PH - Filippine 5
QA - Qatar 5
SA - Arabia Saudita 5
CL - Cile 4
CO - Colombia 4
DO - Repubblica Dominicana 4
KE - Kenya 4
LA - Repubblica Popolare Democratica del Laos 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
CY - Cipro 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RO - Romania 3
SN - Senegal 3
BO - Bolivia 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
LU - Lussemburgo 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
IM - Isola di Man 1
Totale 11.293
Salva come PNG Salva come JPEG
Città #
Chandler 682
Dallas 553
Singapore 545
Southend 490
Hong Kong 411
Ashburn 353
Dublin 251
Verona 219
Beijing 212
Munich 186
Jacksonville 165
Woodbridge 151
Helsinki 147
Ann Arbor 133
Princeton 100
Redmond 97
Lawrence 93
Istanbul 92
The Dalles 80
New York 79
Wilmington 78
Houston 75
Jinan 71
São Paulo 53
Dong Ket 52
Jakarta 52
Nanjing 47
Lancaster 45
Los Angeles 44
Shenyang 44
Sindelfingen 44
Columbus 41
Hebei 39
Milan 39
Turku 37
Lappeenranta 36
Lomé 35
Santa Clara 34
Seattle 33
Tianjin 33
Redwood City 32
Washington 32
Nuremberg 30
Council Bluffs 28
Changsha 27
Vienna 26
Brooklyn 25
Haikou 25
Zhengzhou 25
Ningbo 24
Seoul 24
Guangzhou 23
Taizhou 22
Brussels 21
Ho Chi Minh City 19
Nanchang 19
Amsterdam 18
Hangzhou 17
Norwalk 17
Warsaw 17
Atlanta 16
Chicago 16
Boardman 14
Dongguan 14
Moscow 14
Rome 14
San Francisco 14
Bologna 13
Montreal 13
Padova 13
Paris 13
Sant'Ambrogio di Valpolicella 13
Frankfurt am Main 12
Fuzhou 12
Hanoi 12
Falkenstein 11
London 11
Skopje 11
Stockholm 11
Taiyuan 11
Brasília 10
Chennai 10
Fairfield 10
Porto Alegre 10
Rio de Janeiro 10
Tashkent 10
Tokyo 10
Baku 9
Belo Horizonte 9
Jiaxing 9
Madrid 9
Mexico City 9
Bonndorf 8
Goiânia 8
Lanzhou 8
Phoenix 8
Toronto 8
Boston 7
Clearwater 7
Denver 7
Totale 6.876
Salva come PNG Salva come JPEG
Nome #
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 299
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 196
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 174
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 156
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 144
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 137
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 136
A case of acute fulminant multiple sclerosis treated with alemtuzumab 135
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 126
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 124
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 120
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 119
Assessing response to interferon-β in a multicenter dataset of patients with MS 119
Explainable 3D-CNN for multiple sclerosis patients stratication 118
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 117
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 116
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 115
Epilepsy in multiple sclerosis: The role of temporal lobe damage 115
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 114
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 114
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 113
Response to Nagai et al. 111
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 111
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 110
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 109
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 107
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 107
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 104
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 104
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 103
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 103
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 103
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 103
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 102
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 101
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 101
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 100
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 100
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 100
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 99
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 98
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 96
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 96
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 95
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 93
Multiple sclerosis and epilepsy: much more than a coincidence 93
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 93
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 92
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 92
Exploring the origins of grey matter damage in multiple sclerosis. 91
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 91
Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection 89
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 88
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 87
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 86
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. 86
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 85
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 85
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 85
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 84
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 83
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 83
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 83
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 82
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 82
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 81
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 81
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 81
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 80
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 77
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 77
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 75
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 74
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 73
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 71
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 71
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 71
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 69
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 69
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 69
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 69
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 68
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 68
Cortical gray matter MR imaging in multiple sclerosis 68
Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria 68
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis 68
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 67
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 67
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 67
Informing MS patients on treatment options: a consensus on the process of consent taking 66
Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment 65
The BAFF / APRIL system as therapeutic target in multiple sclerosis 65
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis 65
Explainable deep learning for decrypting disease signatures in multiple sclerosis 64
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 64
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 63
Social cognition in multiple sclerosis: a 3-year follow-up {MRI} and behavioral study 63
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 62
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 61
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 60
Totale 9.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.861
article - articoli 47.462
book - libri 0
conference - conferenze 5.053
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 346
Totale 105.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 44 77 95 75 32 20 49 34 68 79
2021/2022870 48 263 5 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/20253.674 140 169 144 615 159 203 205 223 620 250 315 631
2025/20261.702 720 580 402 0 0 0 0 0 0 0 0 0
Totale 11.573